Acurion
Immediate Precision, Optimal Care
San Diego, United States · Founded 2021 · $4.3M raised
- Headquarters
- San Diego
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- acurionhealth.com
- Total Funding
- $4.3M
- Last Round
- $4.3M SeedApr 2026
- Rounds
- 1
About
Acurion (formerly io9) develops OncoGaze™, an AI-powered platform that reads tumor biology from standard pathology slides to identify clinically actionable biomarkers in minutes. The platform currently detects homologous recombination deficiency (HRD) in breast and ovarian cancer, enabling oncologists to identify up to three times more patients eligible for life-extending therapies. Validated in over 1,400 patients and published in the Journal of Clinical Oncology, Acurion raised a $4.3M oversubscribed seed round led by TK & Partners.
Summary
Acurion is an Artificial Intelligence company based in San Diego, United States, founded in 2021. It has raised $4.3M in total across 1 round, most recently a $4.3M Seed round in Apr 2026.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2026
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...